While WellPoint Inc. and its predecessors have a history of grooming new CEOs in-house, the next leader of the health insurance giant is likely to be an outsider, according to interviews with more than a half dozen former directors and officers of the company.
Federal and state prosecutors have collected more than $30 billion from drug companies for alleged fraud and illegal marketing over the last 20 years, according to a new report by consumer advocacy group Public Citizen.
Chicago-based recruiting firm Spencer Stuart & Associates Ltd. has previously led executive and board director hunts for companies including Facebook Inc., Comcast Corp., Talbots Inc. and Hewlett-Packard Co.
You know things are bad in the fiercely competitive pharma industry when drugmakers start turning to each other for help. But that’s exactly what happened last week when 10 major drug companies—including Eli Lilly and Co.—joined forces to cut costs out of clinical trials.
If Indiana expands its Medicaid program as called for under President Obama’s health reform law, it likely will hike state spending on the program an extra 13.5 percent—or $516 million annually—by 2020, according to the latest projections from Seattle-based actuarial firm Milliman Inc.
Novo Nordisk A/S, the world’s largest insulin maker, plans to spend $100 million on research in China. The move follows a similar one by Indianapolis-based Eli Lilly, which opened a 150-person research center in Shanghai in May.
A European committee has endorsed the use of Eli Lilly and Co.'s erectile dysfunction drug Cialis to treat symptoms tied to an enlarged prostate.
WellPoint is seeking a replacement for former CEO Angela Braly, who stepped down Aug. 28 amid shareholder discontent. The company plans to hire a search firm within the next week.
Mainstreet Property Group LLC plans to build a 100-bed facility at 16th Street and Arlington Avenue on nine acres where Raytheon Technical Services Co. LLC once operated.
Indiana Gov. Mitch Daniels' team of federal health care overhaul leaders told state lawmakers Wednesday that even without clear answers on the new law, it will cost the state hundreds of millions more in the coming years.
Pharmaceutical industry heavyweights, including Eli Lilly and Co., are teaming up to improve the way experimental drugs are tested so they can get approved, and reach patients, faster.
Since 2007, premiums for high-deductible health plans’ family coverage have grown 32 percent—compared with 30 percent among all health plans, according to survey data from the Kaiser Family Foundation.
The Indianapolis-based health insurer expects the purchase of health insurance to look and feel much more like online retailing than ever before, where brand name, along with price and convenience, win the day.
Purdue University’s Regenstrief Center for Healthcare Engineering will get another $10 million from the Indianapolis-based Regenstrief Foundation, keeping its research going through 2018.
Almost two weeks after Angela Braly was forced out as WellPoint Inc. CEO, the management team she put in place has been told by the board it will stay, said Chief Financial Officer Wayne Deveydt.
A large physician practice in Bloomington remains at an impasse with Anthem Blue Cross and Blue Shield of Indiana less than two months before their contract is set to expire.
Bloomington-based Cook Medical announced a new division to capitalize on the growing market for minimally invasive procedures to fix problems in ears, noses and throats, as well as other maladies of the head and neck.
A $6.4 billion accord for U.S. drug and medical-device reviews is set to unravel just three months after taking effect as lawmakers squabble over budget cutbacks.
Indianapolis-based Nyhart Actuary & Employee Benefits has established its first office on the West Coast with its latest acquisition.
The drugmaker recently drafted social media guidelines it hopes can help it expand its use of social media to more of its employees—without running afoul of regulators.
